These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10434585)

  • 1. [MPTP parkinsonism].
    Kondo T
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):37-40. PubMed ID: 10434585
    [No Abstract]   [Full Text] [Related]  

  • 2. The MPTP story: MAO activates tetrahydropyridine derivatives to toxins causing parkinsonism.
    Maret G; Testa B; Jenner P; el Tayar N; Carrupt PA
    Drug Metab Rev; 1990; 22(4):291-332. PubMed ID: 2253555
    [No Abstract]   [Full Text] [Related]  

  • 3. [Parkinsonism and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (review of the literature)].
    Atadzhanov MA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(4):117-21. PubMed ID: 1650080
    [No Abstract]   [Full Text] [Related]  

  • 4. [MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and parkinsonism].
    Gao XM; Ku BS
    Sheng Li Ke Xue Jin Zhan; 1989 Apr; 20(2):161-3. PubMed ID: 2686017
    [No Abstract]   [Full Text] [Related]  

  • 5. Toxins and Parkinson's disease: MPTP parkinsonism in humans and animals.
    Kopin IJ
    Adv Neurol; 1987; 45():137-44. PubMed ID: 3493621
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical and biochemical parameters of parkinsonism induced by 1-methyl-4-phenyl-1,2,2,6-tetrahydropyridine and its methyl-phenyl and methoxy-phenyl derivatives in C57Bl/6 mice].
    Lermontova NN; Soliakov LS; Bachurin SO; Serkova TP; Petrova LN; Dranyĭ OA; Tkachenko SE; Kalashnikov VV
    Biull Eksp Biol Med; 1990 Oct; 110(10):397-9. PubMed ID: 2279092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of major olfactory dysfunction in MPTP-induced parkinsonism.
    Doty RL; Singh A; Tetrud J; Langston JW
    Ann Neurol; 1992 Jul; 32(1):97-100. PubMed ID: 1642478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deuterium isotope effects for the oxidation of 1-methyl-3-phenyl-3-pyrrolinyl analogues by monoamine oxidase B.
    Pretorius A; Ogunrombi MO; Terre'blanche G; Castagnoli N; Bergh JJ; Petzer JP
    Bioorg Med Chem; 2008 Oct; 16(19):8813-7. PubMed ID: 18799315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's disease. A review.
    Voiculescu V
    Rom J Neurol Psychiatry; 1991; 29(3-4):103-10. PubMed ID: 1820097
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of interaction of the tanycytes of the third ventricle of the brain with the vascular bed endothelium in enzymatic activation of the parkinsonism-inducing proneurotoxin MPTP in rat brain.
    Horský J; Krs O; Bielavský J
    Folia Morphol (Praha); 1990; 38(1):24-7. PubMed ID: 2341077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic aspects of the behavior of MPTP and some analogues.
    Tipton KF; McCrodden JM; Sullivan JP
    Adv Neurol; 1993; 60():186-93. PubMed ID: 8420134
    [No Abstract]   [Full Text] [Related]  

  • 12. [An experimental model of Parkinson disease caused by a neurotoxin: implications in the clinical aspects and the etiology of Parkinson disease].
    Jiménez Jiménez FJ; Ladero Quesada JM
    Med Clin (Barc); 1990 Apr; 94(15):585-95. PubMed ID: 2192210
    [No Abstract]   [Full Text] [Related]  

  • 13. [Parkinsonism and MPTP (methylphenyltetrahydropyridine)].
    Nagatsu T
    No To Shinkei; 1986 Jul; 38(7):706-7. PubMed ID: 3489476
    [No Abstract]   [Full Text] [Related]  

  • 14. Early parkinsonism.
    Calne DB; Stoessl AJ
    Clin Neuropharmacol; 1986; 9 Suppl 2():S3-8. PubMed ID: 3297316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fifteen months' follow-up on bilateral embryonic mesencephalic grafts in two cases of severe MPTP-induced parkinsonism.
    Widner H; Tetrud J; Rehncrona S; Snow BJ; Brundin P; Björklund A; Lindvall O; Langston JW
    Adv Neurol; 1993; 60():729-33. PubMed ID: 8420218
    [No Abstract]   [Full Text] [Related]  

  • 16. Spontaneous blink rates correlate with dopamine levels in the caudate nucleus of MPTP-treated monkeys.
    Taylor JR; Elsworth JD; Lawrence MS; Sladek JR; Roth RH; Redmond DE
    Exp Neurol; 1999 Jul; 158(1):214-20. PubMed ID: 10448434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mild parkinsonism in persons exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Tetrud JW; Langston JW; Garbe PL; Ruttenber AJ
    Neurology; 1989 Nov; 39(11):1483-7. PubMed ID: 2812327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More about parkinsonism after taking ecstasy.
    Sewell RA; Cozzi NV
    N Engl J Med; 1999 Oct; 341(18):1400; author reply 1401. PubMed ID: 10577096
    [No Abstract]   [Full Text] [Related]  

  • 19. MPTP-induced "parkinsonism" in the goldfish.
    Youdim MB; Dhariwal K; Levine M; Markey CJ; Markey S; Caohuy H; Adeyemo OM; Pollard HB
    Neurochem Int; 1992 Mar; 20 Suppl():275S-278S. PubMed ID: 1365442
    [No Abstract]   [Full Text] [Related]  

  • 20. MPTP- but not methamphetamine-induced parkinsonism extends to catecholamine neurons in the gut.
    Natale G; Kastsiuchenka O; Pasquali L; Ruggieri S; Paparelli A; Fornai F
    Ann N Y Acad Sci; 2008 Oct; 1139():345-9. PubMed ID: 18991880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.